Researchers developed an innovative approach -- demonstrated in mouse models and isolated human brain tissue -- to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases. The study introduces a first-of-its-kind blood-brain barrier-crossing conjugate (BCC) system, designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system (CNS).
source https://www.sciencedaily.com/releases/2024/11/241125125221.htm
Microsoft to shut down Exchange Online EWS in April 2027
-
Microsoft announced today that the Exchange Web Services (EWS) API for
Exchange Online will be shut down in April 2027, after nearly 20 years.
[...]
sourc...
7 hours ago
No comments:
Post a Comment